Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 12 of about 12 for MERCK & CO., INC
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 53.94 +0.89 (1.68%) 1.08B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 59.38 -0.28 (-0.47%) 169.28B
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.09 +0.03 (2.83%) 48.12M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 56.49 +0.10 (0.17%) 8.26B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 12.65 0.00 (0.00%) 179.37M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 14.99 +0.32 (2.18%) 1.93B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 47.67 -0.20 (-0.42%)
Amphastar Pharmaceuticals Inc NASDAQ AMPH 10.58 +0.02 (0.20%) 472.43M
Amphastar Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and ...
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.891 +0.069 (8.39%)
ALKERMES PLC DL-,01 FRA 8AK 45.66 +1.54 (3.50%)
NEKTAR THERAPEUTICS FRA ITH 11.69 -0.07 (-0.58%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.000